A positive ANA test? What next?



Similar documents
The ANA Test: All You Need to Know Department of Family and Community Medicine Family Medicine Update April 25, 2014

Rheumatology Labs for Primary Care Providers. Robert Monger, M.D., F.A.C.P Frontiers in Medicine

Testing for RA. The Ideal Lab Test. William M. Wason, MD, PhD 9/24/2010. Confusion Abounds

ANA testing can now be ordered in several ways, depending on the clinical circumstances:

Interpreting Rheumatologic Lab Tests

Systemic Lupus Erythematosus

Autoimmune Diseases More common than you think Randall Stevens, MD

PATTERNS OF ARTHRITIS: LAB AND OTHER TESTING

Overview of Rheumatology

Differential Diagnosis

Structure of the presentation

The Most Common Autoimmune Disease: Rheumatoid Arthritis. Bonita S. Libman, M.D.

Appropriate Serologic Testing to Evaluate Rheumatic Complaints

APPROACH TO THE RHEUMATOLOGICAL PATIENT. Catalina Orozco, MD Rheumatology Associates September 23 rd 2013

(Intro to Arthritis with a. Arthritis) Manager of Education & Services for the Vancouver Island Region of The Arthritis Society

Rheumatology ICD-10 documentation

Recognition and Appropriate Work-Up of the Patient with Rheumatic Disease Prior to Rheumatology Referral: A Joint Effort


Arthritis and Rheumatology. Antoni Chan MBChB, FRCP, PhD Consultant Rheumatologist Royal Berkshire NHS Foundation Trust

RHEUMATOLOGY ICD-10 CROSSWALK

Evaluation of a Child with Elevated Transaminases. Linda V. Muir, M.D. April 11, 2008 Northwest Pediatric Liver Disease Symposium

History and Physical Examination for Rheumatic Disease for MUSC Students

TREATING AUTOIMMUNE DISEASES WITH HOMEOPATHY. Dr. Stephen A. Messer, MSEd, ND, DHANP Professor and Chair of Homeopathic Medicine

NURS 821 Alterations in the Musculoskeletal System. Rheumatoid Arthritis. Type III Hypersensitivity Response

Zika Virus. Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases

3 Rd Year Medical Student Lecture Series. Rheumatology Cases. N. Lawrence Edwards, MD

LAB 1 - Direct agglutination. Serology-the study of the in vitro reactions between antibody and antigen

Dr Sarah Levy Consultant Rheumatology Croydon University Hospital

Nutrition and Toxicants in Autoimmune Disease: Implications for Prevention and Treatment

Differential diagnosis of arthritis. Dr Gabriella Szűcs University of Debrecen Department of Internal Medicine Rheumatology Division

SF-DCT INFORMATION FOR MIXED CONNECTIVE TISSUE DISEASE (MCTD) CLAIMS OPTION 1. (MCTD claims are not eligible for Disease Option 2)

Disclosures. None. Seth Compton, MD Fellow of Rheumatology University of Mississippi Medical Center. Thank you for coming

Systemic Lupus Erythematosus Overview. Clinical presentation, pathophysiology, and therapeutic strategies over the course of disease

Infl ectra for rheumatoid arthritis

Understanding Rheumatoid Arthritis

Critical Issues in School Health Arthritis in the School Setting. Lawrence Zemel MD Tegan Willard RN Connecticut Children s

Corporate Medical Policy

Sovaldi (sofosbuvir) Prior Authorization Criteria

Evaluation of Disorders of the Hands and Wrists

Rheumatoid Arthritis

The Silicone Breast Implant Controversy

Human Normal Immunoglobulin Solution for Intravenous Infusion.

Rheumatoid Arthritis

Requirements for Medical Clearance: History and Physical exam within 6 months of applying for privileges

Tuberculosis Exposure Control Plan for Low Risk Dental Offices

Rheumatoid Arthritis. Nicole Klett,, M.D.

Rheumatoid Arthritis

Disclosures. Consultant and Speaker for Biogen Idec, TEVA Neuroscience, EMD Serrono, Mallinckrodt, Novartis, Genzyme, Accorda Therapeutics

TRINITAS SCHOOL OF NURSING STUDENT HEALTH RECORD

Covers 60 major critical illnesses. Covers 11 minor critical illnesses. ManuMulti Care

Registered Nursing Health Requirements Checklist

SE5h, Sepsis Education.pdf. Surviving Sepsis

LEHMAN COLLEGE DEPARTMENT OF NURSING ANNUAL HEALTH CLEARANCE REQUIREMENTS

Use the steps below to complete the CertifiedBackground (CB) electronic health record tracking process.

Tuberculosis: FAQs. What is the difference between latent TB infection and TB disease?

PATIENT REGISTRATION

Pericardial Effusion. By Nancy Liao

Do I need a physician referral? Yes, we see patients on referral from a health care provider.

Back to Index. 1. Systemic autoimmune disease 1. Introduction

Chronic Illness Benefit application form 2016

Health Information Form for Adults

QUESTIONS AND ANSWERS ABOUT JUVENILE RHEUMATOID ARTHRITIS

Appendix B: Provincial Case Definitions for Reportable Diseases

Rheumatoid arthritis (RA) is a systemic inflammatory disorder which has pleuroparenchymal

How does Vectra DA measure my RA disease activity? What is Vectra DA? The more you and your doctor know about your RA, the better you can manage it

MANAGEMENT OF TUBERCULOSIS

Juvenile Dermatomyositis Joseph Junewick, MD FACR

Health Information Form for Adults

BASIC INFORMATION ABOUT HIV, HEPATITIS B and C, and TUBERCULOSIS Adapted from the CDC

Blood Testing Protocols. Disclaimer

Lupus in Children and Teenagers. Arielle Hay, MD Pediatric Rheumatologist Nicklaus Children s Hospital

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

Once the immune system is triggered, cells migrate from the blood into the joints and produce substances that cause inflammation.

Rheumatoid arthritis: an overview. Christine Pham MD

Current issues in the Diagnosis and Management of Sjogren s Syndrome

Rheumatic Fever Vs. (?) Post Strep Reactive Arthritis ינואר 2009

Summary of the risk management plan (RMP) for Accofil (filgrastim)

Top 50 ICD-10-Codes Description ICD-9-CM Code ICD-10-CM Code

1584 Wesleyan Drive FORM A Norfolk, VA Phone: (757) Health History immunization & Physical Form

Elevated Serum Lactate Dehydrogenase Values in Children with Multiorgan Involvements and Severe Febrile Illness

Arthritis of the Hands

Immune modulation in rheumatology. Geoff McColl University of Melbourne/Australian Rheumatology Association

Goiter. This reference summary explains goiters. It covers symptoms and causes of the condition, as well as treatment options.

GENETIC ANALYSIS OF PSORIASIS AND PSORIATIC ARTHRITIS Department of Dermatology, University of Michigan

Rheumatoid Arthritis. Disease RA Final.indd :23

Anti-nuclear (ANA), anti-double stranded DNA (dsdna) and anti-extractable nuclear antigen (ENA) antibodies

THYROID DISEASE IN CHILDREN

Pulmonary interstitium. Interstitial Lung Disease. Interstitial lung disease. Interstitial lung disease. Causes.

Stickler Syndrome and Arthritis

Gateway Health SM Non-Formulary Prior Authorization Criteria Intravenous Immune Globulin (IVIG)

1419 Salt Springs Road Syracuse, NY (Health Office)

SOLUBLE TUMOR-ASSOCIATED ANTIGENS AND SECONDARY MALIGNANCIES IN AUTOIMMUNE- RHEUMATOID DISEASES

Trinitas School of Nursing Health Clearance Information

Arthritis in Children: Juvenile Rheumatoid Arthritis By Kerry V. Cooke

Pulmonary Associates of Richmond

Maria Dalbey RN. BSN, MA, MBA March 17 th, 2015

Transcription:

A positive ANA test? What next? Lorenzo Dagna, MD Unit of Medicine and Clinical Immunology Università Vita-Salute San Raffaele School of Medicine San Raffaele Scientific Institute, Milan - Italy 4 th International Conference, Society for Acute Medicine, Edinburgh 7-8 October 2010

Why the hell has an ANA test been ordered for this patient?

A positive ANA test - What next? Three clinical cases What is an ANA test When should an ANA test be ordered? Frequently asked questions about ANA

A positive ANA test - What next? Three clinical cases Brief history of ANA testing When should an ANA test be ordered? Frequently asked questions about ANA

Mrs. Smith, 72 y.o. 2-year history of pain in DIPs, PIPs, and knees. Morning stiffness 30-40 min

Mrs. Smith, 72 y.o. Physical: normal Lab: normal (including ESR, CRP, RA test, WR) ANA pos. 1:320 homogeneous pattern

Martha, 31 y.o. 2 weeks: - fever (37.8 C/100.0 F) - arthralgias - erythematous skin rash

Martha, 31 y.o. Physical: HR 92r, BP 110/70, RR 22 Chest: muffling of a respiratory sound in the pulmonary bases Heart: muffled heart sounds Otherwise normal

Martha, 31 y.o. Lab: Hb 10.3 g/dl WBC 3200/mm 3 Plt 198.000/mm 3 crea 1.4 mg/dl ESR 36 mm/hr CRP 12.0 mg/l RA test/wr: neg ANA pos. 1:160 homogeneous pattern

Louise, 28 y.o. Four-month history of weakness, fatigue, arthromyalgias

Louise, 28 y.o. Physical: normal Lab: Hb 12.2 g/dl WBC 4600/mm 3 (diff OK) Plt 212,000/mm 3 ESR 31 mm/hr CRP 9.0 mg/l ANA pos. 1:640 homogeneous pattern

Mrs. Smith, 72 y.o. 2-year history of pain in DIPs, PIPs, and knees, morning stiffness 30-40 min Martha, 31 y.o. Recent travel to Egypt Fever, arthralgias, erythematous skin rash after sun exposure Louise, 28 y.o. Four-month history of weakness, fatigue, arthromyalgias ANA pos. 1:320 homogeneous pattern ANA pos. 1:160 homogeneous pattern ANA pos. 1:640 homogeneous pattern

A positive ANA test - What next? Three clinical cases What is an ANA test When should an ANA test be ordered? Frequently asked questions about ANA

ANAs A family of antibodies to nuclear constituents Best studied with immuno-fluorescencebased tests based on HEp-2 --> homogeneous/diffuse, rim/peripheral, nucleolar, centromeric

Homogeneous speckled

Nucleolar

Centromeric

Speckled

Other ANA tests EIA/ELISA testing --> greater ease of performance --> lower cost of the test For generic ANA: - not subject to widespread population testing - lower sensibility - no possibility to establish the ANA pattern Useful for specific autoabs to nuclear Ags (SSA, SSB, dsdna)

A positive ANA test - What next? Three clinical cases What is an ANA test When should an ANA test be ordered? Frequently asked questions about ANA

No test for ANA and for specific autoantibodies to nuclear antigens should be performed without a clinical evaluation that leads to a presumptive diagnosis Kavanaugh et al. Guidelines for clinical use of the ANA test and tests for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med. 2000;124:71-81.

When shoud an ANA test be ordered?

When is an ANA test useful? To help establishing a diagnosis in a patient with clinical features suggestive of an autoimmune or connective tissue disorder To exclude such disorders in patients with few or uncertain clinical findings To subclassify a patient with an established diagnosis of an autoimmune or connective tissue disease To monitor disease activity

Conditions associated with positive IF-ANA test results Diseases for which an ANA test is very useful for diagnosis - SLE 95-100% - systemic sclerosis (scleroderma) 60-90% Diseases for which an ANA test is somewhat useful for diagnosis - Sjögren syndrome 40-70% - idiopathic inflammatory myositis (dermato/polymyositis) 30-80% Diseases for which an ANA test is useful for monitoring/prognosis - Juvenile chronic oligoarticular arthritis with uveitis 20-50% - Raynaud phenomenon 20-60% Diseases for which a positive ANA test is an intrinsic part of diagnostic criteria - drug-induced SLE 100% - MCTD 100%

Conditions associated with positive IF-ANA test results Diseases for which an ANA test is not useful in diagnosis - rheumatoid arthritis 30-50% - multiple sclerosis 25% - idiopathic thrombocytopenic purpura 10-30% - thyroid disease 30-50% - discoid lupus 5-25% - infectious diseases wide variations - malignancies wide variations - patients with silicone breast implants 15-25% - fibromyalgia 15-25% - healthy relatives of pts with SLE o scleroderma 5-25% Normal young persons* - ANA 1 : 40 20-30% - ANA 1 : 80 10-12% - ANA 1 : 160 5% - ANA 1: 320 3% * Frequency increases with female sex and increasing age

Conditions associated with positive IF-ANA test results Infections classically associated with a positive ANA test - infectious mononucleosis - tuberculosis - HCV infection - HIV infection - subacute bacterial endocarditis Drugs - procainamide - anticonvulsants (phenytoin) - hydralazine - quinidine - minocycline - anti-thyroid drugs - diltiazem - rifampin - penicillamine - beta blockers - isoniazid - lithium - TNF-α blockers - IFN-α

No test for ANA and for specific autoantibodies to nuclear antigens should be performed without a clinical evaluation that leads to a presumptive diagnosis Kavanaugh et al. Guidelines for clinical use of the ANA test and tests for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med. 2000;124:71-81.

Conditions associated with positive IF-ANA test results Diseases for which an ANA test is very useful for diagnosis - SLE 95-100% - systemic sclerosis (scleroderma) 60-90% Diseases for which an ANA test is somewhat useful for diagnosis - Sjögren syndrome 40-70% - idiopathic inflammatory myositis (dermato/polymyositis) 30-80% Diseases for which an ANA test is useful for monitoring/prognosis - Juvenile chronic oligoarticular arthritis with uveitis 20-50% - Raynaud phenomenon 20-60% Diseases for which a positive ANA test is an intrinsic part of diagnostic criteria - drug-induced SLE 100% - MCTD 100%

Conditions associated with positive IF-ANA test results Diseases for which an ANA test is very useful for diagnosis - SLE 95-100% - systemic sclerosis (scleroderma) 60-90% Diseases for which an ANA test is somewhat useful for diagnosis - Sjögren syndrome 40-70% - idiopathic inflammatory myositis (dermato/polymyositis) 30-80% Diseases for which an ANA test is useful for monitoring/prognosis - Juvenile chronic oligoarticular arthritis with uveitis 20-50% - Raynaud phenomenon 20-60% Diseases for which a positive ANA test is an intrinsic part of diagnostic criteria - drug-induced SLE 100% - MCTD 100%

Systemic lupus erythematosus Sensitivity: 95-100% PPV general population: 11-13% Acceptable specificity and positive predictive value ONLY IF there is a reasonable pre test clinical suspicion of SLE should not be used for screening for SLE Kavanaugh A et al., 2000

Systemic sclerosis (scleroderma) Sensitivity: 60-90% a positive ANA test supports the diagnosis in the presence of clinical signs and symptoms a negative ANA test should lead the physician to consider other fibrosing illnesses (linear/local scleroderma, eosinophilic fasciitis, scleredema) Kavanaugh A et al., 2000

Conditions associated with positive IF-ANA test results Diseases for which an ANA test is very useful for diagnosis - SLE 95-100% - systemic sclerosis (scleroderma) 60-90% Diseases for which an ANA test is somewhat useful for diagnosis - Sjögren syndrome 40-70% - idiopathic inflammatory myositis (dermato/polymyositis) 30-80% Diseases for which an ANA test is useful for monitoring/prognosis - Juvenile chronic oligoarticular arthritis with uveitis 20-50% - Raynaud phenomenon 20-60% Diseases for which a positive ANA test is an intrinsic part of diagnostic criteria - drug-induced SLE 100% - MCTD 100%

Sjögren syndrome Idiopathic inflammatory myopathies Sensitivity: 40-70% (SS) / 30-80% (IIM) a positive ANA test supports the diagnosis in the presence of the specific clinical signs and symptoms a negative ANA test does not rule out the diagnosis Fossaluzza A et al., 1992; Love M, 1991

Raynaud phenomenon (RP) primary RP (81%): patients who will never develop a systemic rheumatic disease secondary RP (19%): patients who will develop a rheumatic disease (SLE, RA, SScl, ) An ANA test in patients with RP if positive, increases the likelihood of a secondary RP (19% 30%) if negative, reduces the likelihood of a secondary RP (19% 7%) Spencer-Green G, 1998

A positive ANA test - What next? Three clinical cases What is an ANA test When should an ANA test be ordered? Frequently asked questions about ANA

ANA: FAQs Q: If the ANA result is negative, should be the test repated or should other tests be done (ENA)? A: No, if errors in testing are not suspected

ANA: FAQs Q: What other testing should be done following a positive ANA test result? A: Different tests, according to the suspected diagnosis

ANA Positive What next? Diagnosis SLE Test dsdna, Sm, Ro/SSA, La/SSB, acl, anti-beta2-gpi, LLAC Sjogren Ro/SSA, La/SSB, RF, Waaler-Rose PM/DM Jo1 (anti-synthetase syndrome) Systemic sclerosis Centromere (CREST), Scl70 (diffuse) Drug induced-sle Histones H2A/H2B

ANA: FAQs Q: What tests should be performed in young women with symmetric arthralgias? A: 1) arthralgias (not arthritis) 6 wks: nothing Viruses frequently: HBV,HCV, rubella (also vaccine), parvo occasionally: EBV, HIV, mumps, HAV, coxsackie, echo, adeno, VZV, HSV, CMV 2) arthralgias 6 wks or arthritis: further investigation warranted

Q: What tests should be performed in young women with symmetric arthralgias 6 wk or arthritis? ANA: FAQs A: RF & ANA if RF positive, consider RA also in the presence of a positive ANA a positive ANA with negative RF does not rule out RA (7.5% of pts with RA are RF-/ANA+ [typically anti-histones]) If ANA strongly pos & RF neg/low titer: anti-ds-dna, anti-sm, anti-rnp, anti-centromere, anti-scl-70, anti-ro/ssa, La-SSB consider autoimmune hepatitis, Hashimoto s thyroiditis, Lyme disease

ANA: FAQs Q: My patient has anti-phospholipid syndrome (APS). Should an ANA test be performed? A: - ANA test is not useful for diagnosing APS - 40-50% of patients with APS have ANA A positive ANA test in patients with APS increases the likelihood that APS is secondary to SLE Petri M, 1994

ANA: FAQs Q: What other testing should be after in an ANA positive asymptomatic patient? A:?????

Why the hell has an ANA test been ordered for this patient? Dagna L. et al., unpublished

You may have a rheumatic disorder.

Murphy s law on doctors Lyall s Principle Just because doctors have a name for your condition doesn t mean they know what it is.

No test for ANA and for specific autoantibodies to nuclear antigens should be performed without a clinical evaluation that leads to a presumptive diagnosis Kavanaugh et al. Guidelines for clinical use of the ANA test and tests for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med. 2000;124:71-81.

ANA: FAQs Q: What other testing should be after in an ANA positive asymptomatic patient? A: Nothing more.. but

Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus Melissa R. Arbuckle, M.D., Ph.D., Micah T. McClain, Ph.D., Mark V. Rubertone, M.D., R. Hal Scofield, M.D., Gregory J. Dennis, M.D., Judith A. James, M.D., Ph.D. and John B. Harley, M.D., Ph.D. N Engl J Med Volume 349;16:1526-1533 October 16, 2003

Autoantibodies appear years before the onset of autoimmune diseases Systemic lupus erythematosus (dsdna, SSA/SSB, Sm) Scleroderma (centromere, Scl-70) Sjögren syndrome (Ro/SSA, La/SSB) Rheumatoid arthritis (CCP) Autoimmune myositis (trna synthetases) Primary biliary cirrhosis (mitochondria E2) T1DM, autoimmune thyroiditides, celiac disease, pemphigus, multiple sclerosis, vitiligo, Lyons R. et al., Ann NY Acad Sci 2005; Scofield RH, Lancet 2004

René Magritte, L èchelle du feu, 1934

Conditions associated with positive IF-ANA test results Diseases for which an ANA test is not useful in diagnosis - rheumatoid arthritis 30-50% - multiple sclerosis 25% - idiopathic thrombocytopenic purpura 10-30% - thyroid disease 30-50% - discoid lupus 5-25% - infectious diseases wide variations - malignancies wide variations - patients with silicone breast implants 15-25% - fibromyalgia 15-25% - healthy relatives of pts with SLE o scleroderma 5-25% Normal young persons* - ANA 1 : 40 20-30% - ANA 1 : 80 10-12% - ANA 1 : 160 5% - ANA 1: 320 3% * Frequency increases with female sex and increasing age

Frequency of ANA positivity increases with female sex and increasing age

So what to do?

Always consider history, physical and simple lab tests

Patient with a significantly positive ANA test evaluate Skin ± joint involvement drug exposure Raynaud, sclerodactyly, myositis, teleangectasis esophageal & lung involvement Sicca symptoms dsdna,rnp,sm, SSA/SSB, apl histones Scl-70, PM/Scl centromere, RNP, Jo-1 SSA/SSB drug SLE SSc MCTD DM/PM Sjogren induced LE

Conditions associated with positive IF-ANA test results Diseases for which an ANA test is not useful in diagnosis - rheumatoid arthritis 30-50% - multiple sclerosis 25% - idiopathic thrombocytopenic purpura 10-30% - thyroid disease 30-50% - discoid lupus 5-25% - infectious diseases wide variations - malignancies wide variations - patients with silicone breast implants 15-25% - fibromyalgia 15-25% - healthy relatives of pts with SLE o scleroderma 5-25% Normal young persons* - ANA 1 : 40 20-30% - ANA 1 : 80 10-12% - ANA 1 : 160 5% - ANA 1: 320 3% * Frequency increases with female sex and increasing age

A positive ANA test - What next? Three clinical cases What is an ANA test When should an ANA test be ordered? Frequently asked questions about ANA

Mrs. Smith, 72 y.o. 2-year history of pain in DIPs, PIPs, and knees, morning stiffness 30-40 min Martha, 31 y.o. Recent travel to Egypt Fever, arthralgias, erythematous skin rash after sun exposure Louise, 28 y.o. Four-month history of weakness, fatigue, arthromyalgias ANA pos. 1:320 homogeneous pattern ANA pos. 1:160 homogeneous pattern ANA pos. 1:640 homogeneous pattern

Mrs. Smith, 72 y.o. 2-year history of pain in DIPs, PIPs, and knees, morning stiffness 30-40 min ANA pos. 1:320 homogeneous pattern

Mrs. Smith, 72 y.o. Physical: normal Lab: normal (including ESR, CRP, RA test, WR) ANA pos. 1:320 homogeneous pattern

Mrs. Smith, 72 y.o. Hand XRay: narrowing of joint spaces, no erosions

Mrs. Smith, 72 y.o. D: primary ostearthritis ANA: aspecific Rx: Coxibs

Martha, 31 y.o. 2 weeks: - fever (37.8 C/100.0 F) - arthralgias - erythematous skin rash

Martha, 31 y.o. Physical: HR 92r, BP 110/70, RR 22 Chest: muffling of respiratory sound in the pulmonary bases Heart: muffled heart sounds Otherwise normal

Martha, 31 y.o. Lab: Hb 11.8 g/dl WBC 3200/mm 3 Plt 198.000/mm 3 crea 1.4 mg/dl ESR 36 mm/hr CRP 12.0 mg/l RA test/wr: neg ANA pos. 1:160 homogeneous pattern

Martha, 31 y.o. Chest Xray: bilateral pleural effusion, cardiac shadow enlargement

Martha, 31 y.o. Lab: anti-ds-dna pos anti-sm neg anti-ssa/ssb neg anti-β2-gpi neg Urinalysis w/ proteinuria & micro: pending res.

5-6 /11

Martha, 31 y.o. D: idiopathic SLE Rx: PDN 1 mg/kg

Louise, 28 y.o. Four-month history of weakness, fatigue, arthromyalgias

Louise, 28 y.o. Physical: normal Lab: Hb 12.2 g/dl WBC 4600/mm 3 (diff OK) Plt 212,000/mm 3 ESR 31 mm/hr CRP 9.0 mg/l ANA pos. 1:640 homogeneous pattern

Louise, 28 y.o. Lab: anti-ds-dna neg anti-sm neg anti-ssa/ssb neg

Louise, 28 y.o. Lab: anti-tpo 1210 U/L anti-tg 890 U/L ft3 0.1 ng/dl ft4 0.65 ng/dl TSH 8.26 mu/l

Louise, 28 y.o. D: Hashimoto s thyroiditis Rx: levothyroxin 50 μg

Mrs. Smith, 72 y.o. 2-year history of pain in DIPs, PIPs, and knees, morning stiffness 30-40 min ANA pos. 1:320 homogeneous pattern Martha, 31 y.o. Recent travel to Egypt Fever, arthralgias, erythematous skin rash after sun exposure ANA pos. 1:160 homogeneous pattern Louise, 28 y.o. Four-month history of weakness, fatigue, arthromyalgias ANA pos. 1:640 homogeneous pattern D: primary ostearthritis D: idiopathic SLE D: Hashimoto s thyroiditis

Take home messages No test for ANA should be performed without a clinical evaluation that leads to a presumptive diagnosis (SLE, SSc, Sjögren, PM/DM, JCOA, Raynaud, drug-induced SLE, autoimmune hepatic disease, MCTD) ANA testing have an extremely low specificity and PPV in the general population. ANA and ENA are different tests (ANA more sensitive, anti-ena more specific)

Take home messages (2) Many diseases may cause ANA positivity; many healthy individuals have a positive ANA test. Some ANA patterns (nucleolar, centromeric) can be more specific than others (diffuse, homogeneous, speckled). Patient referred for a positive ANA should be evaluated considering for signs and symptoms of the above mentioned disease. If those are absent, no further investigations may be warranted.

René Magritte, La trahison des images, 1928-29